baber/WOPTO huggingface dataset:
Patent NZ-331030-A (NZ)
Title: Bioluminescent novelty items consisting of novelty items and bioluminescence generating system
Inventor: BRYAN BRUCE J
IPC: A23L5/40
Filed: 1997-02-03
Abstract: Disclosed is apparatus for generating bioluminescence, and combinations of these systems and apparatus with inanimate articles of manufacture to produce novelty items. These novelty items, which are articles of manufacture, are designed for entertainment, recreation and amusement, and include toys, paints, slimy play material, textiles, particularly clothing, bubbles in bubble making toys and other toys that produce bubbles, balloons, personal items, such as bath powders, body lotions, gels, powders and creams, tooth-pastes, soaps, body paints, and bubble bath, foods, such as gelatins, icings and frostings, beverages such as beer, wine, champagne, soft drinks, and glowing ice, fountains, including liquid "fireworks" and other such jets or sprays or aerosols of compositions that are solutions, mixtures, suspensions, powders, pastes, particles or other suitable formulation. Cartridges for charging and/or recharging the novelty items with bioluminescence generating systems are also provided.
Patent NZ-334065-A (NZ)
Title: Compositions containing hedgehog proteins bound to a hydrophilic carrier for use in the local release of these proteins on bone and cartilage
Inventor: LANG KURT
IPC: A61K35/12
Filed: 1999-02-04
Abstract: A pharmaceutical composition which comprises a hedgehog protein and is useful for treating bone and cartilage disorders. In the composition, the hedgehog protein is ionically bound to a polymer (hydrophilic carrier) which contains 0.1-2 negatively charged residues per monomer in the form of acidic groups and has a molecular weight of at least 50kDa. The polymer releases the hedgehog protein in a delayed manner in vivo.
Patent NZ-334516-A (NZ)
Title: Labyrinth bearing seal, interlocking stator and rotator
Inventor: SHARRER KENNETH J
IPC: F16J15/447
Filed: 1997-10-08
Abstract: A labyrinth bearing seal includes a stator 16 which is attached to bearing housing 14, and rotator 18 which rotates with shaft 12.  The stator includes an annular engagement flange 48.  The rotator has annular flange 66 which bears against the outer face of flange 48, and also has a flange 64 which fits within a groove 42 in the stator.  The engagement of flanges 64 and 66 with flange 48 mechanically interlock the rotator and stator.  The flanges 48 and 64 have notches that allow the two to be rotated past each other to interlock them.
Patent NZ-504567-A (NZ)
Title: Dispersed resins comprising a carboxylic acid, an amine, a complex crosslinking agent of a metal, a resin or oil, and a thickener; for use in coating compositions
Inventor: BAKER GARY
IPC: C09D167/08
Filed: 1998-12-03
Abstract: An aqueous composition, which comprises a reaction product of: i) At least one carboxylic acid containing from 3 to 22 carbon atoms; ii) At least one unsubstituted or substituted aliphatic amine or polyfunctional aromatic amine, containing from 2 to 25 carbon atoms or an amide of the formula R-C(O)-NR1R2, where R, R1 and R2 each independently represent hydrogen or an optionally substituted alkyl group of 1 to 5 carbon atoms; iii) A complex crosslinking agent of a metal which is zinc, aluminium, titanium, copper, chromium, iron, zirconium or lead. iv) A resin or an oil, the weight ratio of the resin or oil to the sum of (i), (ii) and (iii) being at least 2.5:1; and v) A thickener, a continuous dry layer obtained by applying the composition to Western Red Cedar providing a contact angle with water not exceeding 80o. Also described is the use of the composition described above to prepare an aqueous coating composition such that a continuous dry layer obtained by applying the coating composition to Western Red Cedar provides a contact angle with water not exceeding 80o.
Patent NZ-505194-A (NZ)
Title: Isolated strains of staphylococcus aureus and vaccines against bovine mastitis
Inventor: TRAININ ZE EV
IPC: A61K39/085
Filed: 1998-12-29
Abstract: Staphylococcus aureus strain BS449, ZO3984 and VLVL8407 are provided.  The strains are deposited and registered in the CNM Collection nationale de Cultures de Microorganismes Institut Pasteur under the identification references I-1950, I-1951 and I-1952 respectively.  Strain BS449 is â-haemolytic, coagulase positive and phage type 81.  Strain Z03984 is â-hemolytic, coagulase positive and phage type 3/A, 3/C, 55 and 71.  Strain VLVL8407 is unhemolytic, coagulase positive and phage untypable. The strains may be used in a vaccine against the occurrence of bovine mastitis.
Patent NZ-507641-A (NZ)
Title: Nk cell activation inducing ligand (nail) dna and polypeptides and use thereof
Inventor: KUBIN MAREK Z
IPC: C12N15/09
Filed: 1999-03-23
Abstract: CD48 protein is a counter-structure of NK-cell activator inducing ligand (NAIL) polypeptides.  The binding together of these two components forms complexes.  Disclosed herein is a method of screening for CD48 and for inhibitors of the binding of CD48 to NAIL polypeptides.  Also disclosed is an isolated NAIL nucleic acid molecule selected from the group consisting of : (a) the DNA sequence of SEQ ID NO: 1; (b) an isolated nucleic acid molecule encoding an amino acid sequence comprising the sequence of SEQ ID NO: 2; (c) a nucleic acid molecule that hybridizes to either strand of a denatured, double-stranded DNA comprising the nucleic acid sequence of (a) or (b) under conditions of moderate stringency in 50% formamide and 6XSSC, at 42 C with washing conditions of 60 C, 0. 5XSSC, 0.1% SDS, and having 80% identity to SEQ ID NO:2; (d) fragments of (a)-(c) comprising at least 25 contiguous nucleotides; and the use of such polypeptides for inhibiting the proliferation of cancer cells.
Patent NZ-509118-A (NZ)
Title: Formulations for controlling human lice containing spinosyn
Inventor: SNYDER DANIEL EARL
IPC: A61K31/70
Filed: 1999-06-21
Abstract: A formulation for controlling a lice infestation comprises a spinosyn or a physiologically acceptable derivative or salt thereof and a physiologically acceptable carrier. A spinosyn is a macrolide produced by the cultivation of Saccharopolyspora spinosa.  Each spinosyn has a 12-membered macrocyclic ring that is part of an unusual tetracyclic ring system to which two different sugars are attached, the amino-sugar forosamine and the neutral sugar 2N,3N,4N-tri-O-methylrhamnose. The term "spinosyn or a physiologically acceptable derivative thereof" refers to an individual spinosyn factor (A, B, C, D, E, F, G, H, J, K, L, M, N, O, P, Q, R, S, T, U, V, W or Y), an N-demethyl derivative of an individual spinosyn factor, or a combination thereof.
Patent NZ-509572-A (NZ)
Title: Process for generating electric energy, steam and carbon dioxide from hydrocarbon feedstock
Inventor: NILSEN HENNING REIER
IPC: C01B32/50
Filed: 1998-07-13
Abstract: A process for the production of electrical energy, steam and carbon dioxide in concentrated form from a hydrocarbon feedstock. Said process comprising: formation of synthesis gas in an air driven autothermal reactor unit (ATR); heat exchanging the formed synthesis gas and thereby producing steam; characterised in that at least part of the synthesis gas is treated in a CO-shift reactor unit and carbon dioxide separation units, for formation of concentrated carbon dioxide and a lean hydrogen containing gas which is at least partly combusted in a combined cycle gas turbine for production of electric energy, and where air from said turbine is supplied to the ATR unit, such that the exhaust from the gas turbine is heat exchanged for production of steam, which is combined with steam generated by the CO shift reactor unit and utilized in a power generator for the production of electric energy with a substantially CO2- free exhaust gas.
Patent NZ-515063-A (NZ)
Title: A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor
Inventor: ABRAHAMSSON TOMMY
IPC: A61K38/00
Filed: 2000-05-03
Abstract: Pharmaceutical formulations of an inhibitor of carboxypeptidase U (CPU) and a low molecular weight thrombin inhibitor in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as a kit of parts, a method for treatment and use of the formulations for the treatment of a condition in which inhibition of CPU and/or inhibition of thrombin are required or desired are disclosed.
Patent NZ-516134-A (NZ)
Title: Looper and cutter drive mechanism for sewing machine
Inventor: KOUICHI SAKUMA
IPC: D05B73/02
Filed: 2001-03-05
Abstract: In a looper and cutter drive mechanism for sewing machine, an upper looper and a lower looper are respectively disposed below a throat plate, respective loop-taker points of these loopers are arranged in the same direction such that the loop-taker points pass a front side of the needle as seen in the stitching direction. The upper looper and the lower looper are driven such that the upper looper and the lower looper perform movements having traces on planes substantially parallel to each other. Due to such a constitution, the looper drive mechanism has both of the lockstitching function and the over-edge stitching function and can perform both functions by a single sewing machine. Further, the rotational movement of an upper shaft of the sewing machine is transferred to the upward and downward movement by way of a motion transfer mechanism which is operated in an interlocking manner with the rotational movement and a fabric edge is cut by an upper cutter which is operated corresponding to the upward and downward movement and a lower cutter which is cooperatively operated with the upper cutter. Here, the upper cutter is slidably guided by a cutter drive portion which is pivotally mounted on a frame. The motion transfer mechanism is connected to the upper cutter by way of a clutch. The clutch transfers power to the upper cutter at the time of performing the cutters of the cutter drive portion and pivotally moves the cutter drive portion to a shunting position and interrupts the transmission of power to the upper cutter at the time of not performing the cutters
Patent NZ-516566-A (NZ)
Title: Wind energy facility with a closed cooling circuit
Inventor: WOBBEN ALOYS
IPC: F03D11/00
Filed: 2000-04-27
Abstract: A cooling system for a wind energy facility which reduces losses in the facility.  The wind energy facility (1) has a fully or at least partially closed cooling circuit, whereby the heat to be dissipated from the cooling circuit is evacuated by means of the tower (3) or the nacelle (2) of the wind energy facility (1).
Patent NZ-516642-A (NZ)
Title: Protecting laminate for automotive carpeting
Inventor: THELE BERNHARD
IPC: B32B27/32
Filed: 2000-07-06
Abstract: A thermoplastic laminate comprising i) a first outer layer comprising an ethylene homo- or co-polymer; ii) a core layer comprising a polyamide; iii) a second outer layer comprising a thermoplastic polyurethane. The thermoplastic laminate is used as an intermediate protective laminate in the manufacture of a polyurethane padded carpet wherein a polyurethane foam layer is formed on the surface of the protective laminate in its turn hot bonded to an upper fibrous layer.
Patent NZ-519679-A (NZ)
Title: RNA polymerases from bacteriophage PHI 6-PHI 14 and use thereof
Inventor: MAKEYEV EUGENY
IPC: C12P19/34
Filed: 2000-12-21
Abstract: The use of an isolated polymerase protein having an unspecified capability of RNA synthesis in vitro when contacted with nucleic acid substrates under conditions appropriate for in vitro synthesis, for producing RNA in vitro, the protein being encoded by a nucleic acid sequence selected from the group comprising: (a) a nucleic acid sequence having at least a partial nucleic acid sequence of SEQ ID NO:1; (b) a nucleic acid sequence encoding a polypeptide having at least a partial amino acid sequence of SEQ ID NO: 8; (c) a nucleic acid sequence which differs from the nucleic acid sequence of (a) or (b) due to degeneracy of the genetic code; (d) a nucleic acid sequence hybridizing to the nucleic acid sequence of (a), (b) and/or (c); and (e) a nucleic acid sequence encoding an amino acid sequence which shows at least 20% identity, preferably at least 50% identity to a sequence contained in (b); wherein the protein preferably originates form Cystoviridae, Retroviridae, birnaviridae or Totiviridae viruses and more particularly where the protein originates from phi6-related bacteriophages from the family Cystoviridae.
Patent NZ-521154-A (NZ)
Title: 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds and pharmaceuticals thereof, and the use of these compounds for the treatment or prevention of a functional or inflammatory disorder in the lower intestinal tract in mammals
Inventor: JASSERAND DANIEL
IPC: A61P1/00
Filed: 2002-09-03
Abstract: A compound of the general formula (I) is described, along with a process for its preparation, a medicament containing this compound, and the use of the medicament for the treatment of a functional or inflammatory disorder in the lower intestinal tract.
Patent NZ-523219-A (NZ)
Title: Modulation of abscisic acid signal transduction in plants
Inventor: SCHROEDER JULIAN
IPC: C12N15/82
Filed: 2001-06-14
Abstract: A method of modulating abscisic acid signal transduction in a plant, comprising introducing into the plant an expression cassette comprising a promoter operably linked to an ABH1 polynucleotide sequence in the sense or antisense orientation wherein the ABH1 polynucleotide sequence (a) comprises a sequence at least 70% identical to SEQ ID NO: 1 or (b) that encodes an ABH1 polypeptide having a sequence at least about 70% identical to SEQ ID NO: 2 (a nuclear cap binding protein CBP80); an expression cassette comprising said sequence and a transgenic plant transformed with said expression cassette wherein the plant has enhanced drought tolerance and/or decreased expression of ABH1.
Patent NZ-523306-A (NZ)
Title: An event handling system
Inventor: ANDERSON MARK STEPHEN
IPC: G06F17/50
Filed: 2002-04-30
Abstract: An event handling system to schedule and translate semantic deductions from Intelligent Agents and sensors into events capable of being made observable by a Recipient system such as monitor that provides a particular view of virtual objects and events is disclosed. The event handling system also encapsulates the system's notion of time. In fact, a human observer can shift the system along the temporal axis (up to the present) in order to replay events, or undertake analyses as a result of speeded-up or slowed-down notions of system time. The event handling system receives events from Clients/Sources via connections through the event handling system Input Portals, and uses Shared Memory as its form of inter-process communication with the Monitors. The event handling system makes events available for a recipient observation sub-system to read and provide their particular view. There can be many Clients and Recipient systems connected to the event handling system at the same time.
Patent NZ-525997-A (NZ)
Title: Packaging cell lines for subgroup B recombinant adenoviruses
Inventor: VOGELS RONALD
IPC: C12N5/08
Filed: 2001-11-14
Abstract: Disclosed is packaging cell line developed specifically for complementing recombinant adenovirus based on a serotype from subgroup B, particularly adenovirus serotype 35, wherein the cell line developed form primary diploid human cells or derivatives thereof transformed with either an E1 coding sequence from a subgroup B adenovirus, a chimeric E1 construct including E1A and at least part of an E1B-21K coding sequence from subgroup C and a E1B-55K coding sequence from subgroup B, or an adenovirus E1 coding sequence from subgroup C plus a E1B-55K coding sequence from subgroup B.
Patent NZ-529669-A (NZ)
Title: Use of reactive polymeric surfactants in the formation of emulsions
Inventor: HEMING ALEXANDER MARK
IPC: C09K23/54
Filed: 2002-06-10
Abstract: Disclosed is a process for the production of an oil-in-water emulsion having an oil discontinuous phase and an aqueous continuous phase which process comprises reacting (i)a polymeric stabilizer of formula (I) which is a random graft copolymer or a block copolymer, comprises a plurality of vinylic monomers and which is soluble or dispersible in the continuous phase, wherein: G is a group * or hydrophile, R1, R and R2 are each independently H or methyl, X is a hydrophilic moiety, L is a moiety containing a cross-linking group capable of undergoing a cross-linking nucleophilic or condensation reaction at the interface of dispersed and continuous phases of said emulsion, wherein said cross linking group is selected from -SH, -OH, -NHA where A is defined, Y is a hydrophobic moiety; With (ii) one or more substances dissolved in the liquid discontinuous oil phase which react with said cross-linking group. Additionally disclosed is a process for the production of microcapsules using the above described oil-in-water emulsion.
Patent NZ-533436-A (NZ)
Title: Catheter injectable depot compositons and uses thereof
Inventor: CHEN GUOHUA
IPC: A61K9/06
Filed: 2002-11-14
Abstract: Catheter injectable depot compositions are provided that include a bioerodible, biocompatible polymer, a solvent having miscibility in water of less than or equal to 7 wt.% at 25 DEG C, in an amount effective to plasticize the polymer and form a gel therewith, a thixotropic agent, and a beneficial agent. The solvent comprises an aromatic alcohol, an ester of an aromatic acid, an aromatic ketone, or mixtures thereof. The compositions are have substantially improved the shear thinning behaviour and reduced injection force, rendering the compositions readily implanted beneath a patient's body surface by injection.
Patent NZ-536639-A (NZ)
Title: New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
Inventor: BARKOCZY JOZSEF
IPC: C07B61/00
Filed: 2002-12-28
Abstract: Described are piperidinyl-alkylamino-pyridazinone derivatives of the general Formula (I) (wherein R is hydrogen or C1-4alkyl; one of X and Y stands for hydrogen and the other represents a group of the general Formula (II) Hal stands for halogen; and n is 1 or 2) and pharmaceutically acceptable acid addition salts thereof. Also described is a process for the preparation of these piperidinyl-alkylamino-pyridazinone derivatives and pharmaceutical compositions comprising these compounds. The compounds of the general Formula I exhibit an anxiolytic effect and can be used in the treatment of anxiety disorders.
Patent NZ-537798-A (NZ)
Title: Bubble-seal apparatus for easily opening a sealed package
Inventor: PERELL WILLIAM S
IPC: B65D33/00
Filed: 2003-08-21
Abstract: A storage pack is provided with a band seal 14 across the enclosure on the edge of the pack, the band seal including inner 14I and outer 14O seal portions separated by a breaching bubble 16. By applying exterior pressure to the bubble the outer seal portion is breached to separate the opposed laminae of the package at the outer edge of the package. The separated opposed flaps at the edge of the package can then be gripped to be peeled apart to also separate the laminae at the inner seal and thereby open the package.
Patent NZ-542025-A (NZ)
Title: Method for producing the enantiomeric forms of cis 1,3-cyclohexanediol derivatives using stereoselective enzymatic ester formation or enzymatic ester hydrolysis
Inventor: HOLLA WOLFGANG
IPC: C07D263/32
Filed: 2004-02-19
Abstract: Disclosed are methods for producing chiral, non-racemic, cis 1,3-disubstituted cyclohexanols of formula (I), in which the groups are defined as cited in the description, using an enzymatic resolution of racemates.
Patent NZ-542250-A (NZ)
Title: Virus therapeutic drug
Inventor: AOKI MASAHIRO
IPC: A61P1/16
Filed: 2004-02-12
Abstract: Compounds of formula (I), wherein A represents a phenyl group substituted with -OX or a 3-indolyl group and the remaining substituents are as defined in the specification, can be used to treat or prevent viral infections such as HCV. Certain novel compounds of formula (I) are also disclosed.
Patent NZ-545134-A (NZ)
Title: Modulation of eIF4E expression
Inventor: FREIER SUSAN M
IPC: A61K38/00
Filed: 2004-09-17
Abstract: Provided is a modified antisense oligonucleotide targeting eukaryotic initiation factor 4E (eIF4E), comprising a specified nucleotide sequence having at least one chemically modified sugar moiety, internucleoside linkage, or nucleobase, or a pharmaceutically acceptable salt thereof. Further provided are specific modified sugars in said oligonucleotides, pharmaceutical compositions comprising the oligonucleotides and use of the oligonucleotides for the manufacture of a medicament for the treatment of a condition or disease associated with eIF4E expression or overexpression.
Patent NZ-548743-A (NZ)
Title: Novel indeno[2,1A]indenes and isoindol[2,1-A]indoles
Inventor: JASTI VENKATESWARLU
IPC: C07D487/04
Filed: 2004-12-30
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds are indeno[2,1a]indene and isoindolo[2,1a]indole derivatives useful in the treatment of disorders that involve 5-HT receptors (serotonin), for example CNS disorders, haematological disorders, eating disorders, diseases associated with pain, respiratory diseases, genito-urological disorders, cardio vascular diseases and cancer.
Patent NZ-552146-A (NZ)
Title: An apparatus and method for leak detection in flexible packages
Inventor: ELIASSON MATTS
IPC: G01M3/36
Filed: 2005-06-07
Abstract: A method and apparatus for leak detection in flexible packages is disclosed. The method involves locating a flexible fluid containing package (2) in a sealed chamber (1) and evacuating air from the chamber to a predetermined pressure value. An initial measurement of a reference dimension (h1) of the package is made by a sensor (8) and after a predetermined period of time a second measurement of the reference dimension (h1) is made by the sensor (8) to detect any change in that reference dimension as indicative of a leakage of fluid from the package (2).
Patent NZ-552343-A (NZ)
Title: Manufacture of sodium hypochlorite bleach
Inventor: POWELL DUANE J
IPC: B01F23/00
Filed: 2005-07-12
Abstract: A process and apparatus for the manufacture of high-strength, low-salt hypochlorite, especially sodium hypochlorite, wherein high-strength is at least 25% sodium hypochlorite and low-salt is less than about 9.5% sodium chloride is disclosed. An aqueous solution that comprises certain weight percentages of sodium hypochlorite and sodium hydroxide and that is essentially free of sodium chloride (salt) crystals, an aqueous solution that comprises a certain weight percentage of sodium hydroxide, and chlorine in gas and/or liquid phase that may or may not include inerts are reacted in a tank. This creates a solution having a precipitation zone where salt crystals are precipitating out of solution and falling downward to form a slurry, some of which is withdrawn, then cooled, and then re-introduced into the precipitation zone. Above the precipitation zone is a crystal-free mother liquor zone consisting essentially of crystal-free mother liquor containing a weight percentage of sodium hypochlorite greater than that of than the lower strength aqueous sodium hypochlorite bleach being reacted.